Oxford Immunotec Global PLC·4

Mar 13, 4:32 PM ET

Linn Stefan C 4

4 · Oxford Immunotec Global PLC · Filed Mar 13, 2020

Insider Transaction Report

Form 4
Period: 2020-03-11
Linn Stefan C
Chief Operating Officer
Transactions
  • Award

    Ordinary Shares

    2020-03-11+37,23596,301 total
  • Award

    Share Option (Right to Buy)

    2020-03-11+37,23537,235 total
    Exercise: $12.19Exp: 2030-03-11Ordinary Shares (37,235 underlying)
Footnotes (2)
  • [F1]Options granted under Issuer's 2013 Share Incentive Plan.
  • [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2021 through January 1, 2024.

Documents

2 files